Improving Public Cancer Care by Implementing Precision Medicine in Norway
Condition:  Cancer Metastatic Intervention:  Drug: Atezolizumab Sponsors:  Oslo University Hospital;  Haukeland University Hospital;  St. Olavs Hospital;  University Hospital of North Norway;  University Hospital, Akershus;  Vestre Viken Hospital Trust;  Hospital of Southern Norway Trust;  Ostfold Hospital Trust;  The Hospital of Vestfold;  Helse Stavanger HF;  Nordlandssykehuset HF;  Sykehuset Innlandet HF;  Helse Forde;  Helse Fonna HF;  Helse Nord-Trøndelag HF;  Helse Møre og Romsdal HF;  Sykehuset Telemark Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials